“…Twenty studies provided comparative data on tumor metastasis between the two groups ( 4 , 6 , 13 – 15 , 17 , 18 , 20 , 25 , 27 , 30 , 33 – 36 , 38 , 40 – 43 ), including 434 patients in the PSM group and 8298 patients in the NSM group. In 4 studies ( 13 , 14 , 35 , 36 ), the number of metastatic cases in the two groups was zero, and the OR value could not be calculated. Pooled data showed a significantly higher rate of metastasis in the PSM group (OR 4.63, 95% CI 3.11-6.88; p < 0.00001), and similar results could be observed in subgroup analyses ( Figure 3 ).…”